1. de Villiers TJ, Hall JE, Pinkerton JV, Cerdas Pérez S, Rees M, Yang C, Pierroz DD. Revised global consensus statement on menopausal hormone therapy. Climacteric. 2016;19(4):313–5. https://doi.org/10.1080/13697137.2016.1196047.
2. Taylor HS, Pal L, Seli E. Speroff’s clinical gynecologic endocrinology and infertility. 9th ed. Philadelphia, PA: Wolters Kluwer; 2020. p. 614–5.
3. Bhavnani BR. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc Soc Exp Biol Med. 1998;217(1):6–16. https://doi.org/10.3181/00379727-217-44199. PMID: 9421201.
4. Sengar G, Tripathy P. Pharmaceutical regulatory agencies and organizations around the world: scope and challenges in drug development. In: Rx Pharmatutor pharmacy encyclopedia; 2012. Pharmatutor-Art-1316. https://www.pharmatutor.org/articles/pharmaceutical-regulatory-agencies-and-organizations-around-world-scope-challenges-in-drug-development. Accessed 29 Mar 2021.
5. Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2012;2012(8):CD000402.